Product Information

ERY-TAB DR 500 MG TABLET is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $3.3278 per EA under NDC 24338012603. Its NADAC has been published 272 times since Feb 7, 2018.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERY-TAB DR 500 MG TABLET

Erythromycin
$3.3278per EA

Strength

500 mg/1

NDC

24338012603

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA062298

FDA Approved

Before 1982

TE Code

AB

On Market Since

4/18/2011

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERY-TAB DR 500 MG TABLET has been published 272 times since Feb 7, 2018, and over the history we have for it it has declined 63.8%. The table below summarizes its recorded NADAC range and movement.

Current price$3.3278 per EA
All-time high$11.0273 (Mar 13, 2019)
All-time low$2.9231 (Jun 17, 2026)
52-week high$3.5114
52-week low$2.9231
Median price$4.8465
Average price$5.7095
Largest weekly change-42.2% (May 18, 2022)
Weeks tracked272
Tracking sinceFeb 7, 2018

Price History

1W

0.0%

1M

+6.9%

3M

+12.3%

6M

+11.9%

1Y

-9.3%

3Y

-31.3%

5Y

-69.8%

All

-63.8%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERY-TAB DR 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ERY-TAB DR 500 MG TABLET, manufactured by Arbor Pharmaceuticals, Inc., is $3.3278 per EA (NDC 24338012603), effective Nov 11, 2026.

How has the price of ERY-TAB DR 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for ERY-TAB DR 500 MG TABLET has declined 63.8%. It has been tracked across 272 weekly CMS publications since Feb 7, 2018.

What are the highest and lowest recorded NADAC prices for ERY-TAB DR 500 MG TABLET?

Since Feb 7, 2018, the NADAC for ERY-TAB DR 500 MG TABLET has ranged from a low of $2.9231 (Jun 17, 2026) to a high of $11.0273 (Mar 13, 2019), with a median of $4.8465 per EA.

Are there cheaper alternatives to ERY-TAB DR 500 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 500 MG TABLET, is $2.5417 per EA — about 24% below ERY-TAB DR 500 MG TABLET.

Who manufactures ERY-TAB DR 500 MG TABLET?

ERY-TAB DR 500 MG TABLET (NDC 24338012603) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.